Abstract

The purpose of this project is to test the safety and efficacy of gramicidine, an anti-herpes-simplex virus compound for the therapy of herpes simplex keratitis (HSK) in rabbits and mice.

Proposed Commercial Applications

NOT AVAILABLE

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY012927-01A2
Application #
6337887
Study Section
Special Emphasis Panel (ZRG1-SSS-R (10))
Program Officer
Fisher, Richard S
Project Start
2001-09-30
Project End
2002-06-29
Budget Start
2001-09-30
Budget End
2002-06-29
Support Year
1
Fiscal Year
2001
Total Cost
$100,000
Indirect Cost

  Institution

Name
Metatron, Inc.
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10022